342 related articles for article (PubMed ID: 16224817)
81. Proliferation requirements of cytomegalovirus-specific, effector-type human CD8+ T cells.
van Leeuwen EM; Gamadia LE; Baars PA; Remmerswaal EB; ten Berge IJ; van Lier RA
J Immunol; 2002 Nov; 169(10):5838-43. PubMed ID: 12421965
[TBL] [Abstract][Full Text] [Related]
82. Rapid expansion of cytomegalovirus-specific cytotoxic T lymphocytes by artificial antigen-presenting cells expressing a single HLA allele.
Papanicolaou GA; Latouche JB; Tan C; Dupont J; Stiles J; Pamer EG; Sadelain M
Blood; 2003 Oct; 102(7):2498-505. PubMed ID: 12805061
[TBL] [Abstract][Full Text] [Related]
83. Releasing the concept of HLA-allele specific peptide anchors in viral infections: A non-canonical naturally presented human cytomegalovirus-derived HLA-A*24:02 restricted peptide drives exquisite immunogenicity.
Pump WC; Schulz R; Huyton T; Kunze-Schumacher H; Martens J; Hò GT; Blasczyk R; Bade-Doeding C
HLA; 2019 Jul; 94(1):25-38. PubMed ID: 30912293
[TBL] [Abstract][Full Text] [Related]
84. Phenotypic and functional separation of memory and effector human CD8+ T cells.
Hamann D; Baars PA; Rep MH; Hooibrink B; Kerkhof-Garde SR; Klein MR; van Lier RA
J Exp Med; 1997 Nov; 186(9):1407-18. PubMed ID: 9348298
[TBL] [Abstract][Full Text] [Related]
85. Intraocular human cytomegaloviruses of ocular diseases are distinct from those of viremia and are capable of escaping from innate and adaptive immunity by exploiting HLA-E-mediated peripheral and central tolerance.
Shirane M; Yawata N; Motooka D; Shibata K; Khor SS; Omae Y; Kaburaki T; Yanai R; Mashimo H; Yamana S; Ito T; Hayashida A; Mori Y; Numata A; Murakami Y; Fujiwara K; Ohguro N; Hosogai M; Akiyama M; Hasegawa E; Paley M; Takeda A; Maenaka K; Akashi K; Yokoyama WM; Tokunaga K; Yawata M; Sonoda KH
Front Immunol; 2022; 13():1008220. PubMed ID: 36341392
[TBL] [Abstract][Full Text] [Related]
86. Coordinated expression of Ig-like inhibitory MHC class I receptors and acquisition of cytotoxic function in human CD8+ T cells.
Anfossi N; Doisne JM; Peyrat MA; Ugolini S; Bonnaud O; Bossy D; Pitard V; Merville P; Moreau JF; Delfraissy JF; Dechanet-Merville J; Bonneville M; Venet A; Vivier E
J Immunol; 2004 Dec; 173(12):7223-9. PubMed ID: 15585844
[TBL] [Abstract][Full Text] [Related]
87. Activity and phenotype of natural killer cells in peptide transporter (TAP)-deficient patients (type I bare lymphocyte syndrome).
Zimmer J; Donato L; Hanau D; Cazenave JP; Tongio MM; Moretta A; de la Salle H
J Exp Med; 1998 Jan; 187(1):117-22. PubMed ID: 9419217
[TBL] [Abstract][Full Text] [Related]
88. CD8+ T cell responses against TAP-inhibited cells are readily detected in the human population.
Lampen MH; Verweij MC; Querido B; van der Burg SH; Wiertz EJ; van Hall T
J Immunol; 2010 Dec; 185(11):6508-17. PubMed ID: 20980626
[TBL] [Abstract][Full Text] [Related]
89. Identification and characterization of HLA-A24-specific XBP1, CD138 (Syndecan-1) and CS1 (SLAMF7) peptides inducing antigens-specific memory cytotoxic T lymphocytes targeting multiple myeloma.
Bae J; Hideshima T; Zhang GL; Zhou J; Keskin DB; Munshi NC; Anderson KC
Leukemia; 2018 Mar; 32(3):752-764. PubMed ID: 29089645
[TBL] [Abstract][Full Text] [Related]
90. HLA-restricted T lymphocyte-mediated cytotoxicity against herpes simplex virus-infected cells in humans.
Yasukawa M; Shiroguchi T; Kobayashi Y
Infect Immun; 1983 Apr; 40(1):190-7. PubMed ID: 6187690
[TBL] [Abstract][Full Text] [Related]
91. Peptide transporter-independent, stress protein-mediated endosomal processing of endogenous protein antigens for major histocompatibility complex class I presentation.
Schirmbeck R; Reimann J
Eur J Immunol; 1994 Jul; 24(7):1478-86. PubMed ID: 8026512
[TBL] [Abstract][Full Text] [Related]
92. HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function.
Appay V; Nixon DF; Donahoe SM; Gillespie GM; Dong T; King A; Ogg GS; Spiegel HM; Conlon C; Spina CA; Havlir DV; Richman DD; Waters A; Easterbrook P; McMichael AJ; Rowland-Jones SL
J Exp Med; 2000 Jul; 192(1):63-75. PubMed ID: 10880527
[TBL] [Abstract][Full Text] [Related]
93. Human peptide transporter deficiency: importance of HLA-B in the presentation of TAP-independent EBV antigens.
de la Salle H; Houssaint E; Peyrat MA; Arnold D; Salamero J; Pinczon D; Stevanovic S; Bausinger H; Fricker D; Gomard E; Biddison W; Lehner P; UytdeHaag F; Sasportes M; Donato L; Rammensee HG; Cazenave JP; Hanau D; Tongio MM; Bonneville M
J Immunol; 1997 May; 158(10):4555-63. PubMed ID: 9144467
[TBL] [Abstract][Full Text] [Related]
94. The varicellovirus-encoded TAP inhibitor UL49.5 regulates the presentation of CTL epitopes by Qa-1b1.
van Hall T; Laban S; Koppers-Lalic D; Koch J; Precup C; Asmawidjaja P; Offringa R; Wiertz EJ
J Immunol; 2007 Jan; 178(2):657-62. PubMed ID: 17202325
[TBL] [Abstract][Full Text] [Related]
95. Constitutive transduction of peptide transporter and HLA genes restores antigen processing function and cytotoxic T cell-mediated immune recognition of human melanoma cells.
White CA; Thomson SA; Cooper L; van Endert PM; Tampe R; Coupar B; Qiu L; Parsons PG; Moss DJ; Khanna R
Int J Cancer; 1998 Feb; 75(4):590-5. PubMed ID: 9466661
[TBL] [Abstract][Full Text] [Related]
96. Cross-reactive anti-viral T cells increase prior to an episode of viral reactivation post human lung transplantation.
Nguyen TH; Westall GP; Bull TE; Meehan AC; Mifsud NA; Kotsimbos TC
PLoS One; 2013; 8(2):e56042. PubMed ID: 23405250
[TBL] [Abstract][Full Text] [Related]
97. The size and phenotype of virus-specific T cell populations is determined by repetitive antigenic stimulation and environmental cytokines.
Gamadia LE; van Leeuwen EM; Remmerswaal EB; Yong SL; Surachno S; Wertheim-van Dillen PM; Ten Berge IJ; Van Lier RA
J Immunol; 2004 May; 172(10):6107-14. PubMed ID: 15128796
[TBL] [Abstract][Full Text] [Related]
98. NKG2C
Grutza R; Moskorz W; Senff T; Bäcker E; Lindemann M; Zimmermann A; Uhrberg M; Lang PA; Timm J; Cosmovici C
J Immunol; 2020 Jun; 204(11):2910-2917. PubMed ID: 32284334
[TBL] [Abstract][Full Text] [Related]
99. Distinctive phenotype for HLA-E- versus HLA-A2-restricted memory CD8 αβT cells in the course of HCMV infection discloses features shared with NKG2C
Rousselière A; Gérard N; Delbos L; Guérif P; Giral M; Bressollette-Bodin C; Charreau B
Front Immunol; 2022; 13():1063690. PubMed ID: 36532017
[TBL] [Abstract][Full Text] [Related]
100. Cytomegalovirus (CMV) Epitope-Specific CD4
Abana CO; Pilkinton MA; Gaudieri S; Chopra A; McDonnell WJ; Wanjalla C; Barnett L; Gangula R; Hager C; Jung DK; Engelhardt BG; Jagasia MH; Klenerman P; Phillips EJ; Koelle DM; Kalams SA; Mallal SA
J Immunol; 2017 Nov; 199(9):3187-3201. PubMed ID: 28972094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
